These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

445 related articles for article (PubMed ID: 1567181)

  • 1. Antitumor effects of three platinum complexes, (-)-(R)-2-aminomethylpyrrolidine(1,1-cyclobutanedicarboxylato)-platinum (II) monohydrate (DWA2114R), cis-diammine-(1,1-cyclobutanedicarboxylato)platinum(II) (CBDCA) and cis-diamminedichloroplatinum(II) (CDDP), in mice.
    Endo K; Akamatsu K; Matsumoto T; Morikawa K; Koizumi M; Mitsui H; Koizumi K
    Anticancer Res; 1992; 12(1):49-58. PubMed ID: 1567181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro antitumor activity of a new platinum complex, DWA2114R against human tumor cell lines.
    Akamatsu K; Saito H; Tsunenari T; Matsumoto T; Morikawa K; Koizumi M; Mitsui H; Koizumi K
    Anticancer Res; 1993; 13(6A):2261-5. PubMed ID: 8297143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of treatment schedule of an antitumor platinum complex, DWA2114R, on the antitumor activity].
    Endo K; Akamatsu K; Matsumoto T; Morikawa K; Koizumi M; Mitsui H; Koizumi K
    Gan To Kagaku Ryoho; 1992 Feb; 19(2):223-8. PubMed ID: 1736834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antitumor activity of a new platinum complex, 2-aminomethyl-pyrrolidine (1, 1-cyclobutanedicarboxylato) platinum (II).
    Endoh K; Akamatsu K; Matsumoto T; Morikawa K; Honda M; Mitsui H; Koizumi M; Koizumi K; Matsuno T
    Anticancer Res; 1989; 9(4):987-91. PubMed ID: 2817826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Combination therapy of a new platinum complex, DWA2114R with various antitumor agents against mouse tumors in vivo].
    Akamatsu K; Endo K; Tsunenari T; Matsumoto T; Kaiho S; Morikawa K; Koizumi M; Mitsui H; Koizumi K
    Gan To Kagaku Ryoho; 1992 Feb; 19(2):229-35. PubMed ID: 1736835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toxicological and tumoricidal evaluations of a new platinum complex, (-)-(R)-2-aminomethylpyrrolidine(1,1-cyclobutanedicarboxylato+ ++)platinum( II) monohydrate, in rats.
    Akamatsu K; Endo K; Matsumoto T; Morikawa K; Koizumi M; Koizumi K; Mitsui H
    Jpn J Cancer Res; 1991 Jun; 82(6):724-31. PubMed ID: 1906857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro and in vivo antineoplastic activity of a new platinum antineoplastic agent, (R)-(-)-1,1-cyclobutanedicarboxylate (2-aminomethylpyrrolidine)-platinum (II) (DWA2114R) on freshly separated human tumor cells and human tumor xenografts transplanted in nude mice--a comparison with cis-diammine-dichloroplatinum (CDDP).
    Nio Y; Imai S; Shiraishi T; Tsubono M; Morimoto H; Tseng CC; Tobe T
    Anticancer Res; 1991; 11(2):761-7. PubMed ID: 2064331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antitumor activity of a new platinum complex, (R)-(-)-2-aminomethylpyrrolidine (1, 1-cyclobutanedicarboxylato) platinum (II), against cisdiamminedichloroplatinum (II)-resistant murine leukemia cell line].
    Akamatsu K; Endo K; Matsumoto T; Kamisango K; Morikawa K; Koizumi M; Mitsui H; Koizumi K; Matsuno T
    Gan To Kagaku Ryoho; 1990 Jan; 17(1):73-8. PubMed ID: 2404458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Antitumor activity of a new platinum complex (R)-(-)-2-aminomethylpyrrolidine (1,1-cyclobutane dicarboxylato) platinum (II) (DWA2114R) by its serial administration].
    Akamatsu K; Endo K; Matsumoto T; Kamisango K; Morikawa K; Koizumi M; Mitsui H; Koizumi K; Matsuno T
    Gan To Kagaku Ryoho; 1989 May; 16(5):2039-43. PubMed ID: 2658840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antitumor activity and cellular accumulation of a new platinum complex, (-)-(R)-2-aminomethylpyrrolidine(1,1-cyclobutanedicarboxylato)platinum( II) monohydrate, in cisplatin-sensitive and -resistant murine P388 leukemia cells.
    Kamisango K; Matsumoto T; Akamatsu K; Morikawa K; Tashiro T; Koizumi K
    Jpn J Cancer Res; 1992 Mar; 83(3):304-11. PubMed ID: 1582895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potent antitumour activity of (-)-(R)-2-aminomethylpyrrolidine (1,1-cyclobutanedicarboxylato)platinum(II) monohydrate (DWA2114R) against advanced L1210 leukaemia in mice.
    Akamatsu K; Endo K; Matsumoto T; Kamisango K; Morikawa K; Koizumi M; Koizumi K
    Br J Cancer; 1992 Nov; 66(5):827-32. PubMed ID: 1419625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the antitumour effects and nephrotoxicity-inducing activities of two new platinum complexes, (-)-(R)-2-aminomethylpyrrolidine(1,1-cyclobutanedicarboxylato+ ++)-platinum (II) monohydrate, and its enantiomeric isomer.
    Matsumoto T; Endoh K; Akamatsu K; Kamisango K; Mitsui H; Koizumi K; Morikawa K; Koizumi M; Matsuno T
    Br J Cancer; 1991 Jul; 64(1):41-6. PubMed ID: 1854626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Establishment and characterization of acquired resistance to platinum anticancer drugs in human ovarian carcinoma cells.
    Misawa T; Kikkawa F; Maeda O; Obata NH; Higashide K; Suganuma N; Tomoda Y
    Jpn J Cancer Res; 1995 Jan; 86(1):88-94. PubMed ID: 7737915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The interactions of (-)-(R)-2-aminomethylpyrrolidine (1,1-cyclobutanedicarboxylato)platinum(II) monohydrate (DWA2114R) and related compounds with deoxyribonucleic acid.
    Morikawa K; Matsumoto T; Matsuoka Y; Koizumi K
    Chem Pharm Bull (Tokyo); 1992 Jan; 40(1):212-9. PubMed ID: 1576676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective protection against cis-diamminedichloroplatinum(II)-induced toxicity in kidney, gut, and bone marrow by diethyldithiocarbamate.
    Bodenner DL; Dedon PC; Keng PC; Katz JC; Borch RF
    Cancer Res; 1986 Jun; 46(6):2751-5. PubMed ID: 3009000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. cis-Amminedichloro(2-methylpyridine) platinum(II) (AMD473), a novel sterically hindered platinum complex: in vivo activity, toxicology, and pharmacokinetics in mice.
    Raynaud FI; Boxall FE; Goddard PM; Valenti M; Jones M; Murrer BA; Abrams M; Kelland LR
    Clin Cancer Res; 1997 Nov; 3(11):2063-74. PubMed ID: 9815598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulatory effect of axial and equatorial ligands on antitumor activities of trans-1R,2R-diaminocyclohexane platinum(IV) complexes.
    Siddik ZH; al-Baker S; Thai G; Khokhar AR
    Anticancer Drug Des; 1994 Apr; 9(2):139-51. PubMed ID: 8166929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Antitumor activity and toxicity of KB-5424 R, a newly developed antitumor platinum compound].
    Yamaguchi H; Kubota T; Takahara T; Takeuchi T; Furukawa T; Kase S; Josui K; Kodaira S; Ishibiki K; Abe O
    Gan To Kagaku Ryoho; 1991 Jun; 18(7):1135-41. PubMed ID: 2053772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of treatment schedule on antitumor activity of glycolate-0,0'-diammineplatinum(II), a new platinum derivative: comparison with cis-diamminedichloroplatinum(II).
    Suzumura Y; Kato T; Ueda R; Ota K
    Anticancer Res; 1989; 9(4):1083-8. PubMed ID: 2817790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Accumulation of cis-diamminedichloroplatinum (II) and its analogues in sensitive and resistant human ovarian carcinoma cells.
    Misawa T; Kikkawa F; Oguchi H; Morikawa Y; Kawai M; Maeda O; Iwata M; Kano T; Furuhashi Y; Tomada Y
    Oncology; 1992; 49(3):173-9. PubMed ID: 1495742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.